EVG vs. PYC, NFX, APTA, FAB, OCTP, IXI, VAL, BSFA, GENF, and ROQ
Should you be buying Evgen Pharma stock or one of its competitors? The main competitors of Evgen Pharma include Physiomics (PYC), Nuformix (NFX), Aptamer Group (APTA), Fusion Antibodies (FAB), Oxford Cannabinoid Technologies (OCTP), IXICO (IXI), ValiRx (VAL), BSF Enterprise (BSFA), Genflow Biosciences (GENF), and Roquefort Therapeutics (ROQ). These companies are all part of the "biotechnology" industry.
Physiomics (LON:PYC) and Evgen Pharma (LON:EVG) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their earnings, profitability, dividends, community ranking, risk, valuation, analyst recommendations, media sentiment and institutional ownership.
0.1% of Physiomics shares are held by institutional investors. Comparatively, 27.8% of Evgen Pharma shares are held by institutional investors. 6.3% of Physiomics shares are held by insiders. Comparatively, 32.4% of Evgen Pharma shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.
Physiomics has higher revenue and earnings than Evgen Pharma.
Physiomics has a beta of 1.78, meaning that its share price is 78% more volatile than the S&P 500. Comparatively, Evgen Pharma has a beta of 1.44, meaning that its share price is 44% more volatile than the S&P 500.
Evgen Pharma received 113 more outperform votes than Physiomics when rated by MarketBeat users. Likewise, 74.23% of users gave Evgen Pharma an outperform vote while only 55.56% of users gave Physiomics an outperform vote.
Evgen Pharma has a net margin of 0.00% compared to Evgen Pharma's net margin of -70.32%. Physiomics' return on equity of -60.57% beat Evgen Pharma's return on equity.
In the previous week, Evgen Pharma's average media sentiment score of 0.00 equaled Physiomics'average media sentiment score.
Summary
Evgen Pharma beats Physiomics on 6 of the 10 factors compared between the two stocks.
Get Evgen Pharma News Delivered to You Automatically
Sign up to receive the latest news and ratings for EVG and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding EVG and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Evgen Pharma Competitors List
Related Companies and Tools
